Clinical analysis of 15 patients with pulmonary lymphangitic carcinomatosis as the first manifestation of gastric cancer

Yin LIU,Feng WANG,Lu-lu CHEN,Qi ZHAO,Jing-jing DING,Yan LI,Mei HUANG,Ying-wei ZHANG,Hou-rong CAI
DOI: https://doi.org/10.3969/j.issn.1009-6663.2017.09.037
2017-01-01
Abstract:Objective To analyze the clinical characteristics of pulmonary lymphangitic carcinomatosis (PLC) as the first manifestation of gastric cancer, in order to enhance the awareness of PLC and reduce the misdiagnosis rate.Methods The clinical data and chest CT of patients with PLC as the first manifestation of gastric cancer from 2006 to 2016 were retrospectively analyzed.Results The ratio of male to female was 1:2.75, and the mean age was 20±67 years old.Most patients had cough and shortness of breath.13 patients were given tumor markers test.CA724 had high levels in 100% patients (13/13), CA199 in 53.8% (7/13) and CA242 in 53.8% (7/13).CT radiographic manifestations included nodular thickening of interlobular septa in 100%, coarse bronchovascular bundle (75%), hilar or mediastinal lymphadenopahty (83.3%) and pleural effusion (66.7%).In the 12 patients, the histologic type of GC was poorly differentiated adenocarcinoma and 3 of them had signet ring cell carcinoma.Conclusion Middle-aged female patients, especially those with poorly differentiated adenocarcinoma are more likely to have PLC from GC.Patients with PLC usually present with respiratory symptoms.Tumor markers and PET/CT are crucial to improve diagnosis rate.
What problem does this paper attempt to address?